SCHEMBL734058

SCHEMBL734058

CCn1cc(C(O)(C(C)c2ccc(-c3ccc(C(=O)O)c(OC)c3)cc2Cl)C(F)(F)F)ccc1=O

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.35
RORC P51449 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ADRB3 P13945 3/20 0.34
ADRB1 P08588 2/20 0.34
KMT2A Q03164 1/20 0.34
CHEK1 O14757 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
RAB9A P51151 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MAPT P10636 1/20 0.33
AKR1C3 P42330 1/20 0.32
AKR1C2 P52895 1/20 0.32
PPARG P37231 2/20 0.32
NEK2 P51955 1/20 0.32
PDE10A Q9Y233 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL754911 1.00 ESR1 (0.35) ESR1RORCSMN1; SMN2ADRB3ADRB1
SCHEMBL753068 0.92 KMT2A (0.35) SMN1; SMN2KMT2ACHEK1KDM4EALDH1A1
SCHEMBL733375 0.92 KMT2A (0.35) SMN1; SMN2KMT2ACHEK1KDM4EALDH1A1
SCHEMBL733422 0.90 ESR1 (0.35) ESR1RORCADRB3ADRB1CHEK1
SCHEMBL755590 0.90 ESR1 (0.35) ESR1RORCADRB3ADRB1CHEK1
SCHEMBL15789758 0.89 KMT2A (0.37) SMN1; SMN2KMT2AMAPTAKR1C3AKR1C2
SCHEMBL753303 0.89 RARB (0.36) RORCAKR1C2PPARG
SCHEMBL734218 0.89 RARB (0.36) RORCAKR1C2PPARG
SCHEMBL15789745 0.87 KMT2A (0.39) SMN1; SMN2KMT2AALDH1A1MAPTPDE10A
SCHEMBL753067 0.87 PDE4B (0.36) SMN1; SMN2AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411361-B1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-06-18 EP claimed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US claimed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US claimed
EP-2411361-B1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-06-18 EP disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 ESR1 390/4885RORC 250/4885SMN1; SMN2 4229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.